Nautilus Biotechnology, Inc. (NAUT)
2.25
+0.43
(+23.63%)
USD |
NASDAQ |
Oct 09, 16:00
2.25
0.00 (0.00%)
Pre-Market: 20:00
Nautilus Biotechnology Shareholders Equity (Quarterly) : 131.11M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 131.11M |
| March 31, 2026 | 144.42M |
| December 31, 2025 | 156.97M |
| September 30, 2025 | 169.14M |
| June 30, 2025 | 181.09M |
| March 31, 2025 | 194.44M |
| December 31, 2024 | 208.73M |
| September 30, 2024 | 223.43M |
| June 30, 2024 | 235.28M |
| March 31, 2024 | 249.49M |
| December 31, 2023 | 265.35M |
| September 30, 2023 | 277.27M |
| June 30, 2023 | 289.67M |
| Date | Value |
|---|---|
| March 31, 2023 | 303.72M |
| December 31, 2022 | 314.92M |
| September 30, 2022 | 325.34M |
| June 30, 2022 | 337.56M |
| March 31, 2022 | 349.71M |
| December 31, 2021 | 363.58M |
| September 30, 2021 | 377.85M |
| June 30, 2021 | 390.04M |
| March 31, 2021 | 143.47M |
| December 31, 2020 | -29.72M |
| September 30, 2020 | 145.59M |
| June 30, 2020 | 0.0133M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 7.363B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Bruker Corp. | 2.381B |
| Danaher Corp. | 52.58B |
| Harvard Bioscience, Inc. | 7.418M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 163.58M |
| Total Liabilities (Quarterly) | 32.46M |
| Debt to Equity Ratio | 0.2122 |
| Current Ratio | 10.14 |
| Net Debt Paydown Yield | 0.13% |